Adaptive Biotechnologies: Why Executive Sales Cloud a Biotech Growth Story

Related Articles

Is Insider Selling a Red Flag for Adaptive Biotechnologies (ADPT) Investors

7 months ago

What Message Do Insider Sales Send About Adaptive Biotechnologies (ADPT)

7 months ago

Adaptive Biotechnologies: Why Insider Selling Casts a Shadow on Its High-Flying Stock

2 months ago

Vaxcyte's Insider Exodus: Why CEO Sales Cloud a Bullish Biotech Narrative

2 months ago

Category

You may also like

Stock News•1 months ago

Adaptive Biotech co-founder raises $15M for new startup to rethink how AI trains on science

Harlan Robins raised $15M for a new startup to rethink AI training on science, after years building datasets at Adaptive Biotechnologies. The funding could reshape scientific AI approaches.

ADPT

Share

Stock News•2 months ago

Adaptive Biotechnologies Q2 Earnings Call Highlights

Adaptive Biotechnologies (ADPT) raised its full-year revenue outlook after Q2 results showed accelerating MRD growth and improved margins. The company also outlined steps to separate its Immune Medici...

ADPT

Share

Stock News•3 months ago

AbCellera Appoints Dr. Lynn Seely to its Board of Directors

AbCellera appointed Dr. Lynn Seely to its board of directors. Seely brings oncology and drug development expertise, which could support the company's pipeline strategy.

ABCL

Share